Evaluation of 3,4-diethoxy substituted thioureas and their thiazole derivatives as potent anti-Alzheimer's agents: Synthesis, DFT, biological activity and molecular modeling investigations

被引:7
作者
Mahmood, Mahnoor [1 ]
Hussain, Zahid [1 ,2 ]
Ullah, Muhammad Zahid [1 ]
Ejaz, Syeda Abida [3 ]
Fayyaz, Ammara [3 ]
Rashid, Umer [1 ]
Iqbal, Jamshed [1 ,2 ]
Mumtaz, Amara [1 ]
机构
[1] COMSATS Univ Islamabad, Dept Chem, Abbottabad Campus, Abbottabad 22060, Pakistan
[2] COMSATS Univ Islamabad, Ctr Adv Drug Res, Abbottabad Campus, Abbottabad 22060, Pakistan
[3] Islamia Univ Bahawalpur, Fac Pharm, Dept Pharmaceut Chem, Bahawalpur 63100, Pakistan
关键词
Thioureas; Thiazoles; Alzheimer's disease; Cholinesterase; Monoamine oxidase; Docking; Simulations; MONOAMINE-OXIDASE-B; DIRECTED LIGANDS; INHIBITORS; DISEASE; BUTYRYLCHOLINESTERASE; DRUG; ACHE; CHOLINESTERASE; GALANTAMINE; THERAPY;
D O I
10.1016/j.molstruc.2024.138760
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
The current research project aims to develop 3, 4-diethoxy substituted thioureas ( 15 -20 ) and thiazoles ( 22 -23, 25 -26 ) analogs as potential anti-Alzheimer's agents. A total of ten derivatives were synthesized and were further characterized with TLC, FTIR, and NMR techniques. In addition, density functional theory (DFT) calculations and molecular modeling were performed to evaluate the electronic properties and anti-Alzheimer's disease potential of the compounds within the active pockets of the targeted enzymes, respectively. During in -vitro testing, it was determined that all analogs exhibited some degree of inhibitory potential, and analogs (15), (16), (19) , and (26) were found to have excellent potency in inhibiting Alzheimer's disease-related enzymes i.e., monoamine oxidaseA, monoamine oxidase-B, acetylcholinesterase (AChE), and butyrylcholinesterase (BChE). Analog (15) demonstrated an IC 50 of 1.33 +/- 0.04 mu M for MAO -A; (16) showed an IC 50 of 1.67 +/- 0.06 mu M for MAO -B, (19) represented an IC 50 of 0.31 +/- 0.02 mu M for AChE, and (26) showed an IC 50 of 0.51 +/- 0.01 mu M for BChE. These compounds have shown a comparable potential with the reference compounds i.e., Clorgyline (for MAO -A), Deprenyl (for MAO -B) and donepezil in case of AChE and BChE, respectively. The study also established a structure-activity relationship and determined that the potency of the analogs depends on the nature, position, number, and electron-donating/-withdrawing effects of the phenyl ring substituents. The identified compounds also exhibited strong binding interactions during molecular docking investigations. Moreover, the most potent complexes of respective targets were found stable during molecular dynamics simulation studies. The findings of the current study revealed that new thioureas and thiazoles analogs exhibited a reactive electronic property, which is essential for anti-cholinesterase activity.
引用
收藏
页数:17
相关论文
共 51 条
[1]   Identification of potent inhibitors of NEK7 protein using a comprehensive computational approach [J].
Aziz, Mubashir ;
Ejaz, Syeda Abida ;
Tamam, Nissren ;
Siddique, Farhan ;
Riaz, Naheed ;
Qais, Faizan Abul ;
Chtita, Samir ;
Iqbal, Jamshed .
SCIENTIFIC REPORTS, 2022, 12 (01)
[2]  
Bendjeddou A., 2016, International Research Journal of Pure and Applied Chemistry, V12, P1, DOI [DOI 10.9734/IRJPAC/2016/27066, 10.9734/irjpac/2016/27066]
[3]   Molecular dynamics simulations at high temperatures of the Aeropyrum pernix L7Ae thermostable protein: Insight into the unfolding pathway [J].
Benrezkallah, Djamila .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2024, 127
[4]   Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders [J].
Binda, C ;
Newton-Vinson, P ;
Hubálek, F ;
Edmondson, DE ;
Mattevi, A .
NATURE STRUCTURAL BIOLOGY, 2002, 9 (01) :22-26
[5]   Current and emerging therapeutic targets of alzheimer's disease for the design of multi-target directed ligands [J].
Blaikie, Laura ;
Kay, Graeme ;
Kong Thoo Lin, Paul .
MEDCHEMCOMM, 2019, 10 (12) :2052-2072
[6]   Propargylamine-derived multitarget-directed ligands: fighting Alzheimer's disease with monoamine oxidase inhibitors [J].
Bolea, Irene ;
Gella, Alejandro ;
Unzeta, Mercedes .
JOURNAL OF NEURAL TRANSMISSION, 2013, 120 (06) :893-902
[7]   Chiral Separation, X-ray Structure, and Biological Evaluation of a Potent and Reversible Dual Binding Site AChE Inhibitor [J].
Catto, Marco ;
Pisani, Leonardo ;
de la Mora, Eugenio ;
Belviso, Benny Danilo ;
Mangiatordi, Giuseppe Felice ;
Pinto, Andrea ;
De Palma, Annalisa ;
Denora, Nunzio ;
Caliandro, Rocco ;
Colletier, Jacques-Philippe ;
Silman, Israel ;
Nicolotti, Orazio ;
Altomare, Cosimo Damiano .
ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (05) :869-876
[8]  
Chintamaneni M., 2012, Int. Sch. Res. Notices, V2012
[9]  
Cokugras A.N., 2003, Turk. J. Biochem, V28, P54
[10]   Acetylcholinesterase Inhibitors: Pharmacology and Toxicology [J].
Colovic, Mirjana B. ;
Krstic, Danijela Z. ;
Lazarevic-Pasti, Tamara D. ;
Bondzic, Aleksandra M. ;
Vasic, Vesna M. .
CURRENT NEUROPHARMACOLOGY, 2013, 11 (03) :315-335